These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12883311)

  • 41. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
    Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease.
    Patrus B; Nasr A; Langer JC; Gerstle JT
    J Pediatr Surg; 2011 Jan; 46(1):184-7. PubMed ID: 21238663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Spasticity after Botulinum Toxin Injection Using Paired-Pulse Transcranial Magnetic Stimulation.
    Chia CH; Li F; Li QY; Qin WT
    Chin Med J (Engl); 2018 Nov; 131(22):2763-2764. PubMed ID: 30425208
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model.
    Coskun H; Duran Y; Dilege E; Mihmanli M; Seymen H; Demirkol MO
    Obes Surg; 2005 Sep; 15(8):1137-43. PubMed ID: 16197786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical applications of botulinum toxin.
    Dressler D
    Curr Opin Microbiol; 2012 Jun; 15(3):325-36. PubMed ID: 22770659
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of obesity by endoscopic gastric intramural injection of botulinum toxin A: a randomized clinical trial.
    Li L; Liu QS; Liu WH; Yang YS; Yan D; Peng LH; Li LY; Meng JY; Wang XD; Ke M
    Hepatogastroenterology; 2012 Sep; 59(118):2003-7. PubMed ID: 22193433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections.
    Aronson AE; McCaffrey TV; Litchy WJ; Lipton RJ
    Laryngoscope; 1993 Jun; 103(6):683-92. PubMed ID: 8502104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is Chemical Pyloroplasty Necessary for Minimally Invasive Esophagectomy?
    Stewart CL; Wilson L; Hamm A; Bartsch C; Boniface M; Gleisner A; Mitchell JD; Weyant MJ; Meguid R; Gajdos C; Edil BH; McCarter M
    Ann Surg Oncol; 2017 May; 24(5):1414-1418. PubMed ID: 28058546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of botulinum toxin injections on the sphincteric compound muscle action potential of the external anal sphincter.
    Jost WH
    Dis Colon Rectum; 1997 Aug; 40(8):995-6. PubMed ID: 9269820
    [No Abstract]   [Full Text] [Related]  

  • 51. Botulinum toxin in the management of the lower limb in cerebral palsy.
    Cosgrove AP; Corry IS; Graham HK
    Dev Med Child Neurol; 1994 May; 36(5):386-96. PubMed ID: 8168657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow  transplantation.
    Galstyan GM; Pashkova MV; Popova OY; Makarova PM; Dubnyak DS; Kuzmina LA; Parovichnikova EN
    Ter Arkh; 2018 Feb; 90(1):60-64. PubMed ID: 30701760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of physical therapy and anti-botulinum toxin antibody on the efficacy of botulinum toxin-A injections in children with spastic cerebral palsy.
    Jang DH; Sung IY
    Dev Neurorehabil; 2014 Dec; 17(6):414-9. PubMed ID: 25372070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
    Shaari CM; Sanders I
    Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous opioids, gastric motility, and gastric emptying.
    Dubois A
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):56B-61B. PubMed ID: 3038652
    [No Abstract]   [Full Text] [Related]  

  • 56. How Taking into Account the Pyloric Tonus Contributes to Treatment Success While Administering Gastric "Botulinum Toxin A" for Weight Loss.
    Kanlioz M; Ekici U
    Obes Surg; 2020 Sep; 30(9):3365-3369. PubMed ID: 32405906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PrabotulinumtoxinA (Jeuveau) for frown lines.
    Med Lett Drugs Ther; 2019 May; 61(1572):79-80. PubMed ID: 31169802
    [No Abstract]   [Full Text] [Related]  

  • 58. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder.
    deSilva B; Crenshaw D; Matrka L; Forrest LA
    Laryngoscope; 2019 Apr; 129(4):808-811. PubMed ID: 30548857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autonomic side effects of Botulinum toxin Type B intravesical injections: report of 4 cases and review of the literature.
    Ghei M; Maraj BH; Nathan S; Malone-Lee J; Miller R
    Int Urol Nephrol; 2006; 38(3-4):543-4. PubMed ID: 17136583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurotensin slows gastric emptying by a transient inhibition of gastric and a prolonged inhibition of duodenal motility.
    Keinke O; Wulschke S; Ehrlein HJ
    Digestion; 1986; 34(4):281-8. PubMed ID: 3743911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.